Compugen Ltd.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Compugen is a biotechnology company developing therapeutic solutions for cancer and autoimmune diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-06 16:30 |
Foreign Filer Report
Immediate Report of Meeting to be held on September 16, 2025
|
English | 255.1 KB | |
| 2025-08-06 16:30 |
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on September 16, 2025
|
English | 160.4 KB | |
| 2025-08-06 16:00 |
Foreign Filer Report
Compugen Reports Second Quarter 2025 Results
|
English | 1.4 MB | |
| 2025-08-06 16:00 |
Foreign Filer Report
Compugen Reports Second Quarter 2025 Results
|
English | 36.3 KB | |
| 2025-07-28 16:00 |
Regulatory News Service
Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resi…
|
English | 93.6 KB | |
| 2025-07-28 16:00 |
Foreign Filer Report
Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resi…
|
English | 36.5 KB | |
| 2025-07-23 16:00 |
Report Publication Announcement
to Release Second Quarter 2025 Results on Wednesday, August 6, 2025, conference…
|
English | 91.0 KB | |
| 2025-07-23 16:00 |
Report Publication Announcement
to Release Second Quarter 2025 Results on Wednesday, August 6, 2025, conference…
|
English | 36.4 KB | |
| 2025-07-21 16:00 |
Foreign Filer Report
Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Plati…
|
English | 468.1 KB | |
| 2025-07-21 16:00 |
Foreign Filer Report
Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Plati…
|
English | 36.5 KB | |
| 2025-06-12 15:59 |
Regulatory News Service
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 92.7 KB | |
| 2025-06-12 15:59 |
Report Publication Announcement
Compugen to Present AI/ML Driven Predictive Computational Research at
Upcoming …
|
English | 36.3 KB | |
| 2025-05-19 16:00 |
Foreign Filer Report
Compugen Reports First Quarter 2025 Results
|
English | 157.5 KB | |
| 2025-05-19 16:00 |
Foreign Filer Report
Compugen Reports First Quarter 2025 Results
|
English | 36.2 KB | |
| 2025-05-13 16:00 |
Foreign Filer Report
Leadership Transitions Effective September 2025
|
English | 484.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
POLAREAN IMAGING PLC | United States of America | POLX | |
|
Poltreg S.A. | Poland | PTG | |
|
Poxel | France | POXEL | |
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT |